
    
      This Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical trial will
      evaluate the efficacy and safety of intravenous Sodium Thiosulfate Injection for treatment of
      acute calciphylaxis-associated pain in chronic hemodialysis patients. Acute calciphylaxis-
      associated pain intensity will be the primary outcome measure.
    
  